Comparative randomized study on the efficaciousness of treatment of BOO due to BPH in patients with prostate up to 100 gr by endoscopic Gyrus prostate resection versus open prostatectomy. Preliminary data

Archivio Italiano di Urologia e Andrologia

Volumn 83, Issue 2, 2011, Pages 88-94

  Giulianelli, Roberto ^a   Brunori, Stefano ^a   Gentile, Barbara Cristina ^a   Vincenti, Giorgio ^a   Nardoni, Stefano ^a   Pisanti, Francesco ^a   Shestani, Teuta ^a   Mavilla, Luca ^a   Albanesi, Luca ^a   Attisani, Francesco ^a   Mirabile, Gabriella ^a   Schettini, Manlio ^a  

^a Villa Tiberia Clinic   (Italy)

Author keywords

Bladder Outlet Obstruction (BOO); Enlarged prostate; Gyrus device; Lower Urinary Tract Symptoms (LUTS); Open prostatectomy (OPSU); Outcomes; Prostate; Prostatic hyperplasia (BPH); Randomized studies; TURP bipolar

Indexed keywords

HEMOGLOBIN;

ADULT; AGED; ARTICLE; BLADDER NECK STENOSIS; DISEASE SEVERITY; ENDOSCOPIC SURGERY; HUMAN; INTERMETHOD COMPARISON; LENGTH OF STAY; LOWER URINARY TRACT SYMPTOM; MAJOR CLINICAL STUDY; MALE; ORGAN WEIGHT; OUTCOME ASSESSMENT; PROSTATE HYPERTROPHY; PROSTATECTOMY; RANDOMIZED CONTROLLED TRIAL; REOPERATION; RESIDUAL URINE; SAFETY; SCORING SYSTEM; SURGICAL EQUIPMENT; TRANSURETHRAL RESECTION; TREATMENT OUTCOME; URINE FLOW RATE;

AGED; ELECTROSURGERY; HUMANS; MALE; ORGAN SIZE; PROSTATE; PROSTATECTOMY; PROSTATIC HYPERPLASIA; PROSTATISM; TRANSURETHRAL RESECTION OF PROSTATE; URINARY BLADDER NECK OBSTRUCTION;

EID: 80051507368     PISSN: 11243562     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Girman C.J, Jacobsen SJ, Tsukamoto T, et al. Health related quality of life associated with lower urinary tract symptoms in four countries. Urology 1998; 51:428.
2. Anderson SO, Rashidkhani B, Karlberg L, et al. Prevalence of lower urinary tract symptoms in men aged 45-79 years: a population-based study of 40.000 Swedish men. BJU Int 2004; 94:327.
3. Rosen R, Altwein J, Boyle P. et al. Lower urinary tract symptoms and male sexual dysfunction: the multinational survey of the aging male (MSAM-7) Eur Urol 2003; 44:637-49. (Pubitemid 37542920)
4. Keoghane SR, Lawrence KC, Gray AM, et al. A double-blind randomized controlled trial and economic evaluation of transurethral resection vs contact laser vaporization for benign prostatic enlargement: a 3-year follow-up. BJU Int 2000; 85:74-8. (Pubitemid 30072453)
5. Down JB, Cochett ATK, Peters PC et al. Transurethral prostatectomy : practice aspects of the dominant operations in American Urology. J Urol 1989; 141:248.
6. Mebust WK, Holtgrewe HL, Cochett ATK, et al. Transurethral prostatectomy : immediate and post-operative complications. A cooperative study of 13 Institutions evaluating 3,885 patients. J Urol 1989; 141:243.
7. Hahn RG, Nilsson A, Farahmand BY, et al. Blood haemoglobin and the long term incidence of acute myocardal infarction after transurethral resection of the prostate. Eur Urol 1997; 31:199.
8. Uchida T, Ohori M, Soh S, et al. Factors influencing morbidity in patients undergoing transurethral resection of the prostate. Urology 1999; 53:98.
9. Kellow NH. Pacemaker failure during transurethral resection of the prostate. Anaestesia, 1993; 48:136-8. (Pubitemid 23083756)
10. Cabelin MA, Te AE, Kaplan SA. Benign prostatic hyperplasia: challenges for the new millennium. Curr Opin Urol 2000; 10:301.
11. Wasson JH, Bubolz TA, Lu-Yao GL, et al. Transuretrhal resection of the prostate among Medicare beneficiaries: 1984 to 1987. For the Patient Outcomes Research Team for Prostatic Disease. J Urol 2000; 164:1212.
12. Neal DE. The national Prostatectomy Audit. Br J Urol 1997; 79:69.
13. Varkarakis J, Bartsch G, Horninger W. Long term morbidity and mortality of transurethral prostatectomy: a 10-year follow-up. Prostate 2004; 58:248-51. (Pubitemid 38168921)
14. Hargreave TB, Heynes CF, Kendrick SW, et al. Mortality after Transurethral and open prostatectomy in Scotland. Br J Urol 1996; 77:547-53. (Pubitemid 26130747)
15. Huang X, Wang K-H, Qu L-J, et al. Bipolar versus monopolar transurethral resection of the prostate: Pathologic Study in Canines. Urology 2007; 70:180-184. (Pubitemid 47081076)
16. Botto H, Lebret T, Barre P, et al. Electrovaporization of the prostate with the Gyrus device. J Endourol 2001; 15:313-6.
17. Eaton AC, Francis RN. The provision of transurethral prostatectomy on a day-case basis using bipolar plasma kinetic technology. BJU 2002; 89:453-7.
18. Borboroglu PG, Krane CJ, Ward JF, et al. Immediate and postoperative complications of transurethral prostatectomy in the 1990's. J Urol 1999; 162:1307.
19. Passavanti G, Pizzuti V, Bragaglia A, et al. The use of bipolar Plasmakinetic resectoscope in endoscopic resection of the prostate: our experience. Urologia 2007; 74:160-163.
20. Abrams P, Griffiths D, Hofner K, et al. The urodynamic assessment of lower urinary tract symptoms. In Chatelain C, Denis L, Foo KT, et al. (eds). Benign Prostatic Hyperplasia. Proceedings of the 5th International Consultation on Benign Prostatic Hyperplasia. Paris, June 25-28, 2000. Paris: Health Publication, Ltd, 2001; 227-281.
21. AUA, Practice Giudelines Committee: AUA guideline on management of benign prostatic hyperplasia (2003). Chapter 1: diagnosis and treatment recommendations. J Urol 2003; 170:530.
22. Aagaard J, Jonler M, Fuglsig S, et al. Total transurethral resection versus minimal transurethral resection of the prostate-a 10-years follow-up study of urinary symptoms, uroflowmetry and residual volume. Br J Urol 2006; 50:563-8.
23. Dunsmuir WD, McFarlane JP, Tan A, et al. Gyrus bipolar electrovaporization vs transurethral resection of the prostate: a randomised prospective single-bind trial with a 1 year. follow up. Prostate Cancer Prostatic Dis 2003; 6:182-6.
24. Issa MM, Young MR, Bulloch. Dilutional hyponatremia of TURP syndrome: a historical event in the 21st century. Urology 2004; 64:298-301. (Pubitemid 39092458)